Weizmann Institute of Science

MUSCLE CULTIVATION STARTUP PROFUSE-TECHNOLOGY WELCOMES RENOWNED TECHNION PROFESSOR TO ITS SCIENTIFIC ADVISORY BOARD

Retrieved on: 
Lundi, avril 22, 2024
Diabetes, Biomedical engineering, Weight loss, Research, Duchenne, Weizmann Institute of Science, Obesity, Biomedicine, Therapy, Cachexia, Patient, Tissue engineering, Regenerative medicine, Sarcopenia, Duchenne muscular dystrophy, Faculty, Ageing, Biotechnology, Pharmaceutical industry

YOKNEAM, Israel, April 22, 2024 /PRNewswire/ -- ProFuse Technology expands its scope as a muscle cultivation startup aiming to enhance patient outcomes by improving treatments for muscle associated diseases and muscle regeneration. The company has appointed Professor Shulamit Levenberg of the Technion Faculty of Biomedical Engineering to its Scientific Advisory Board, to support its effort towards life science applications.

Key Points: 
  • YOKNEAM, Israel, April 22, 2024 /PRNewswire/ -- ProFuse Technology expands its scope as a muscle cultivation startup aiming to enhance patient outcomes by improving treatments for muscle associated diseases and muscle regeneration.
  • The company has appointed Professor Shulamit Levenberg of the Technion Faculty of Biomedical Engineering to its Scientific Advisory Board, to support its effort towards life science applications.
  • She has joined ProFuse Technology's Scientific Advisory Board to bolster the company's effort to develop materials and methodologies for muscle regeneration and maintenance.
  • We are thrilled to welcome Professor Levenberg's to our Scientific Advisory Board, in order to bolster our pioneering innovative approaches towards muscle regeneration and maintenance."

Seed Health Launches Computational Biology Platform, Powered by Most Comprehensive Host-Microbiome Data Set, to Expand Pipeline Beyond the Gut

Retrieved on: 
Jeudi, avril 11, 2024
Genomics, Nature Communications, Menopause, Acceleration, Seed, Phenotype, AI, Dark Ages, Health, Computational biology, Human, Research, DEXA, Weizmann Institute of Science, Metabolism, Disease, Science, Data, Diet, Probiotic, Longevity, CODA, Biomarker, Ageing, TB, Algorithm

BOSTON, April 11, 2024 /PRNewswire/ -- Seed Health today launched CODA, a computational biology platform for the discovery and development of next-generation precision probiotics and microbiome-directed interventions. The platform is powered by the Human Phenotype Project—the world's most comprehensive multi-omics data set, emerging from the lab of computational biologist Professor Eran Segal, Ph.D., at the Weizmann Institute of Science. CODA elucidates previously unknown connections between the microbiome and health to develop targeted, outcome-specific interventions. First programs include cardiometabolic health, brain health, menopause, and longevity.

Key Points: 
  • "Our CODA platform is tracking the health data of tens of thousands of individuals over decades, offering a comprehensive, multi-omics perspective," explained Raja Dhir, Co-Founder of Seed Health.
  • Such insights reveal a clear distinction between biological and chronological age, offering a more comprehensive understanding of health and disease patterns.
  • This comprehensive approach allows us to unravel the complex interactions between diet, supplementation, the microbiome, and multi-system human health more effectively than before."
  • "CODA significantly expands our platform's capacity to realize the full promise of the microbiome," said Ara Katz, Co-CEO and Co-Founder of Seed Health.

Giant Magellan Telescope Expands Global Science Impact with Taiwanese Partner

Retrieved on: 
Mercredi, février 21, 2024
Giant, Astronaut, Engineering, Smithsonian Institution, A&M, House Committee, University of Arizona, ASIAA, Extremely large telescope, Education, Hubble Space Telescope, University, NASA, Australian National University, Electronics, Harvard University, University of Chicago, Life, Giant Magellan Telescope, Chairperson, Astronomy, Carnegie Institution for Science, Telescope, National university, Weizmann Institute of Science, News, Knowledge, Democracy, Texas A&M University, Arizona State University, Research

PASADENA, CA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope today welcomes Academia Sinica Institute of Astronomy and Astrophysics (ASIAA), a distinguished Taiwanese research institute, into its international consortium.

Key Points: 
  • PASADENA, CA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope today welcomes Academia Sinica Institute of Astronomy and Astrophysics (ASIAA), a distinguished Taiwanese research institute, into its international consortium.
  • ASIAA's inclusion expands the consortium to 14 international research institutions, underscoring Giant Magellan’s significance to the global astronomy community and the consortium’s commitment to prioritizing global collaboration for the advancement of science.
  • “We are thrilled to welcome ASIAA into our international consortium of distinguished partners,” said Dr. Walter Massey, Board Chair of the Giant Magellan Telescope.
  • This collective investment in the Giant Magellan Telescope is a testament that science can transcend boundaries and bind humanity together for good.”
    The astronomical research and instrumental development capabilities in Taiwan have received international recognition.

Giant Magellan Telescope Expands Global Science Impact with Taiwanese Partner

Retrieved on: 
Mardi, février 20, 2024
Giant, Astronaut, Engineering, Smithsonian Institution, A&M, House Committee, University of Arizona, ASIAA, Extremely large telescope, Education, Hubble Space Telescope, University, NASA, Australian National University, Electronics, Harvard University, University of Chicago, Life, Giant Magellan Telescope, Chairperson, Astronomy, Carnegie Institution for Science, Telescope, National university, Weizmann Institute of Science, News, Knowledge, Democracy, Texas A&M University, Arizona State University, Research

PASADENA, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope today welcomes Academia Sinica Institute of Astronomy and Astrophysics (ASIAA), a distinguished Taiwanese research institute, into its international consortium.

Key Points: 
  • PASADENA, CA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The Giant Magellan Telescope today welcomes Academia Sinica Institute of Astronomy and Astrophysics (ASIAA), a distinguished Taiwanese research institute, into its international consortium.
  • ASIAA's inclusion expands the consortium to 14 international research institutions, underscoring Giant Magellan’s significance to the global astronomy community and the consortium’s commitment to prioritizing global collaboration for the advancement of science.
  • “We are thrilled to welcome ASIAA into our international consortium of distinguished partners,” said Dr. Walter Massey, Board Chair of the Giant Magellan Telescope.
  • This collective investment in the Giant Magellan Telescope is a testament that science can transcend boundaries and bind humanity together for good.”
    The astronomical research and instrumental development capabilities in Taiwan have received international recognition.

Brian Price Named CEO of Mesirow Wealth Management

Retrieved on: 
Mercredi, mars 6, 2024
Acquisition, Wealth management, RIA, Mesirow, Growth, Hospital, Price, Weizmann Institute of Science, Organization, Investment banking, Management

CHICAGO, March 6, 2024 /PRNewswire/ -- Mesirow, an independent, employee-owned financial services firm, today announced the appointment of Brian D. Price as CEO of Mesirow Wealth Management .

Key Points: 
  • CHICAGO, March 6, 2024 /PRNewswire/ -- Mesirow, an independent, employee-owned financial services firm, today announced the appointment of Brian D. Price as CEO of Mesirow Wealth Management .
  • Since November 2022, he has served as Interim Head of Wealth Management, providing strategic direction while driving strong organic growth as well as inorganic growth through acquisitions and key hires.
  • "Over the past year, under Brian's leadership, our offering to clients has expanded through new capabilities and the acquisition of Front Barnett , a leading RIA," said Natalie Brown , Mesirow CEO.
  • As a Barron's Top 100 RIA firm , Mesirow Wealth Management offers a differentiated approach that places equal emphasis on customized, comprehensive wealth plans that evolve along with clients' lives and expert investment selection in all markets, including access to traditional stock and bond opportunities as well as alternative investments.

Slice Emerges from Stealth with $7 Million Seed Funding to Automate Global Equity Management with AI-powered Compliance and Tax Monitor

Retrieved on: 
Mercredi, février 28, 2024
Engineering, AI, TEL, CPO, Risk, CFOS, HR, Weizmann Institute of Science, Salesforce, Fenwick & West, Legalease Ltd., Life insurance

WILMINGTON, Del. and TEL AVIV, Israel, Feb. 28, 2024 /PRNewswire/ -- Slice, the only global equity platform utilizing AI for continuous compliance, announced today it has emerged from stealth with a $7 million seed funding round led by TLV Partners, with participation from R-Squared Ventures, Jibe Ventures, leading international law firms Wilson Sonsini, Fenwick & West and notable angel investors.

Key Points: 
  • Workforces have become truly global , and as the job market becomes more competitive, equity makes up a significant part of the talent compensation package.
  • The AI-powered platform automatically ensures that all global equity operations are compliant and tax-optimized to maximize and protect the benefits of equity plans, both for employers and employees.
  • Slice is the first to apply LLMs to the world of equity compliance, enabling its pre-trained platform to quickly learn and apply country-specific tax codes and regulations that impact equity awards.
  • We firmly believe they will quickly be able to deliver a new standard for global equity management and compliance."

Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science

Retrieved on: 
Mercredi, janvier 31, 2024
Partnership, Weizmann Institute of Science, Science, Research, Orange, Government, Therapy, Mentorship, Patient, University, Faculty, Biotechnology, Drug discovery, Chemistry, Investment, Biochemistry, Drug development, Biology, AUC, Student, OGB, Technology transfer, Pharmaceutical industry

Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).

Key Points: 
  • Orange Grove’s agreement with the Weizmann Institute of Science includes a formal memorandum of understanding with its academic innovation hub, known as Bina (Bridge, Innovate, Nurture, Advance).
  • Through its collaboration with Bina, Orange Grove will guide and mentor cutting-edge early-stage research taking place across the Weizmann Institute of Science.
  • As part of the collaboration, Orange Grove Bio and Bina will scout for translation of scientific discoveries made by researchers across the Weizmann Institute of Science.
  • Orange Grove Bio fosters strong relationships with technology transfer offices outside of the traditional medical technology hubs of Boston and San Francisco.

AION Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery

Retrieved on: 
Mardi, janvier 30, 2024
Disease, AION, Patient, Biology, Research, Deep learning, Amazon Web Services, Computational biology, BioMed Central, University, AI, Algorithm, AWS, Protein, Doctor of Philosophy, Machine learning, Merck, Treatment, Data science, Weizmann Institute of Science, Medical device

REHOVOT, Israel , Jan. 30, 2024 /PRNewswire/ -- AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the formation of TenAces Biosciences. TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning  to enhance development of treatments for a range of conditions.

Key Points: 
  • TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning  to enhance development of treatments for a range of conditions.
  • TenAces emerged from AION Labs' fifth startup challenge to develop an AI platform to identify naturally occurring protein interactions leading to targeted protein degradation.
  • The platform solution is expected to facilitate the discovery and development of molecular glue therapies for enhanced targeted protein degradation.
  • TenAces is taking a different approach, by applying machine learning to study the various interactions, protein pairs, and multi-dimensional features to predict new molecular glues.

Introducing the Moses/Weitzman Health System First U.S. Primary Care System Focused on Underserved Communities

Retrieved on: 
Jeudi, janvier 18, 2024
Artificial intelligence, Social isolation, EConsult, Learning, Patient, Research, MWHS, Health, Federally Qualified Health Center, Policy, Weizmann Institute of Science, Domestic violence, Community health center, FQHC, Travel, HIV/AIDS, Medicine, Education, Nursing

MIDDLETOWN, Conn., Jan. 18, 2024 /PRNewswire/ -- The Moses/Weitzman Health System (MWHS) celebrates its formation as the first health system in the United States dedicated to primary care delivery and innovation for underserved communities.

Key Points: 
  • MIDDLETOWN, Conn., Jan. 18, 2024 /PRNewswire/ -- The Moses/Weitzman Health System (MWHS) celebrates its formation as the first health system in the United States dedicated to primary care delivery and innovation for underserved communities.
  • The mission of Moses/Weitzman, a not-for-profit system, is to strengthen health care and improve health outcomes for vulnerable populations across the United States and increasingly, the world.
  • Community Health Center, Inc. , a Federally Qualified Health Center (FQHC), provides primary care to people across Connecticut, offers residencies for rising health care professionals, and hosts continuing education for a national audience.
  • "MWHS will travel new roads, learning along the way and defining how a primary health care system can build healthy families and communities."

Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors

Retrieved on: 
Mercredi, décembre 20, 2023
Biology, TAU Ventures, Drug resistance, Science, Neoplasm, Tumor microenvironment, Weizmann Institute of Science, Biotechnology, Purple, Teva Pharmaceuticals, Patient, Escape Room, Pharmaceutical industry

REHOVOT, Israel, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion and drug resistance, today announced the appointment of Dr. Yael Margolin as an independent member of the Company’s Board of Directors.

Key Points: 
  • Dr. Yael Margolin has more than 35 years of experience as senior manager, chief executive officer and board member in venture capital and in the pharmaceutical and biotech industries, leading strategic and business planning, financing, team building, product development and corporate partnerships.
  • Dr. Margolin is a founder of mentoring@8400, a boutique voluntary mentoring program for young CEOs in Israel.
  • Dr. Margolin commented, “Purple’s pipeline of oncologic drugs that focus on harnessing the tumor microenvironment have strong potential.
  • I’m pleased to join this excellent group of executives, researchers, and board members to help advance much needed treatments for patients in need.”
    “We are pleased and honored to have Dr. Margolin join our board.